Pharmaceuticals, Biotechnology and Life Sciences
India’s health ministry is likely to see a substantial increase in funding, after it warned that its programs were short of cash and sought more than $1.2 billion in additional money
Teva’s two asthma treatments for patients older than 12 has been approved by the US Food and Drug Administration (FDA).
Israel’s largest drugmaker, Teva, has came up short yet again against a US courts regarding patent infringement cases.
Israel’s largest drugmaker, Teva, has came up short yet again against a US courts regarding patent infringement cases.
European Commission has approved Novartis’s Votubia (everolimus) dispersible tablets as an adjunctive treatment for patients aged two years and older whose…
TiGenix has enrolled the first patient and treated in a Phase Ib/IIa clinical trial for Cx611 (SEPCELL) in the treatment of severe sepsis in community-acquired pneumonia (CAP).
Novo Nordisk and University of Oxford have expanded their partnership on researching type 2 diabetes, and will open a new research centre in Oxford.
Allergan has ensured permit to update the label for its Avycaz with new data from two third phase clinical trials, about treatining patients with certain complicated urinary tract infections (UTI).
Shield Therapeutics has appointed Capita Registrars Limited as company secretary, after Richard Jones has officially resigned.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended Pfizer’s Xeljanz (tofacitinib citrate)…